Mechanistic Study of GSDME and CXCL10 in SUV39H1-Mediated Pyroptosis and Immune Suppression in Cervical Cancer.
- 1Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- 2Department of Gynecology and Obstetrics, Xi'an No. 3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, China.
Abstract
Cervical cancer (CC) remains a major global health challenge characterized by high incidence and mortality. The histone methyltransferase suppressor of variegation 3-9 homolog 1 (SUV39H1) has emerged as a key epigenetic regulator in tumor progression, but its role in modulating pyroptosis and remodeling of the immune microenvironment in CC remains unclear. In this study, we demonstrate that SUV39H1 promotes CC progression through dual epigenetic regulation, specifically repression of gasdermin E (GSDME) and activation of chemokine (C-X-C motif) ligand 10 (CXCL10). Overexpression of SUV39H1 in HeLa and SiHa cells enhanced histone 3 lysine 9 tri methylation (H3K9me3) deposition at the DFNA5 (GSDME) promoter, resulting in reduced transcription and suppressed GSDME-dependent pyroptosis-like cell death. Interestingly, it also upregulated CXCL10 expression. Functional assays confirmed that SUV39H1 attenuated GSDME-mediated pyroptosis-like cell death and enhanced cell migration via induction of epithelial-mesenchymal transition (EMT). Moreover, SUV39H1 drives CXCL10 secretion, which activates the chemokine (C-X-C motif) receptor 3 (CXCR3) signaling axis in macrophages and upregulates immunosuppressive molecules including programmed death ligand 1 (PD-L1), T cell immunoglobulin and mucin-domain containing-3 (Tim-3), and secreted phosphoprotein 1 (SPP1), thereby fostering an immunosuppressive tumor microenvironment (TME), and these effects appear parallel to GSDME suppression. Collectively, these findings reveal a multifaceted oncogenic role of SUV39H1 in CC, highlighting its potential as a therapeutic target for epigenetic and immunomodulatory intervention.
Related
- Cucurbitacin I induces pyroptosis via NF-κB/TNFR1/caspase-8/caspase-3/GSDME axis for cervical cancer treatment
- Pyroptosis in myocardial ischemia-reperfusion injury: mechanistic pathways and therapeutic prospects.
- Gasdermin D-mediated delivery of caspase inhibitors to suppress pyroptosis
- Exercise-Mediated Regulation of Pyroptosis in Diabetes and Its Complications: Molecular Mechanisms and Translational Perspectives
- Total secondary saponins from Anemone raddeana suppress pancreatic cancer via Caspase-3/GSDME-mediated pyroptosis.
BibTeX
@article{zhang2026mechanistic,
title = {{Mechanistic Study of GSDME and CXCL10 in SUV39H1-Mediated Pyroptosis and Immune Suppression in Cervical Cancer.}},
author = {Li Zhang and Peiting Sheng and Dongge Cai and Ziyue Zhao and Xiaoling Wu and Yan'e Gao},
journal = {Cancer medicine},
year = {2026},
month = nov,
doi = {10.1002/cam4.72468},
url = {https://europepmc.org/article/MED/42968616},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Mechanistic Study of GSDME and CXCL10 in SUV39H1-Mediated Pyroptosis and Immune Suppression in Cervical Cancer.
AU - Li Zhang
AU - Peiting Sheng
AU - Dongge Cai
AU - Ziyue Zhao
AU - Xiaoling Wu
AU - Yan'e Gao
PY - 2026
DA - 2026/11/01
JO - Cancer medicine
DO - 10.1002/cam4.72468
UR - https://europepmc.org/article/MED/42968616
AB - Cervical cancer (CC) remains a major global health challenge characterized by high incidence and mortality. The histone methyltransferase suppressor of variegation 3-9 homolog 1 (SUV39H1) has emerged as a key epigenetic regulator in tumor progression, but its role in modulating pyroptosis and remodeling of the immune microenvironment in CC remains unclear. In this study, we demonstrate that SUV39H1 promotes CC progression through dual epigenetic regulation, specifically repression of gasdermin E (GSDME) and activation of chemokine (C-X-C motif) ligand 10 (CXCL10). Overexpression of SUV39H1 in HeLa and SiHa cells enhanced histone 3 lysine 9 tri methylation (H3K9me3) deposition at the DFNA5 (GSDME) promoter, resulting in reduced transcription and suppressed GSDME-dependent pyroptosis-like cell death. Interestingly, it also upregulated CXCL10 expression. Functional assays confirmed that SUV39H1 attenuated GSDME-mediated pyroptosis-like cell death and enhanced cell migration via induction of epithelial-mesenchymal transition (EMT). Moreover, SUV39H1 drives CXCL10 secretion, which activates the chemokine (C-X-C motif) receptor 3 (CXCR3) signaling axis in macrophages and upregulates immunosuppressive molecules including programmed death ligand 1 (PD-L1), T cell immunoglobulin and mucin-domain containing-3 (Tim-3), and secreted phosphoprotein 1 (SPP1), thereby fostering an immunosuppressive tumor microenvironment (TME), and these effects appear parallel to GSDME suppression. Collectively, these findings reveal a multifaceted oncogenic role of SUV39H1 in CC, highlighting its potential as a therapeutic target for epigenetic and immunomodulatory intervention.
SN - 2045-7634
ER -